Clik here to view.
TÜV Rheinland: Is Nylon Safe Enough to Be a Food Contact Material?
HONG KONG In this era, plastic is a material that is ubiquitous and of crucial importance in our daily lives. Composed of a wide range of monomers, different plastics are endowed with various...
View ArticleClik here to view.
TÜV Rheinland: Notified Body for the New Medical Device Regulation
COLOGNE, Germany TÜV Rheinland LGA Products GmbH is now a notified body for the EU Medical Device Regulation (MDR) 2017/745. The European Medical Device Regulation 2017/745 (MDR) came into effect on...
View ArticleClik here to view.
Ping An AI Disease Prediction Paper First Published on EBioMedicine of the...
SHENZHEN, China On September 21, 2019, “Forecasting Influenza Activity Using Self-Adaptive AI Model and Multi-Source Data in Chongqing, China”, jointly published by Ping An Technology, Chongqing...
View ArticleClik here to view.
Incyte Announces Positive Updated Results from Phase 2 Trial of Pemigatinib...
WILMINGTON, Del. Incyte (Nasdaq:INCY) announces updated results, including the final result for the primary endpoint, from its Phase 2 FIGHT-202 trial evaluating pemigatinib, a selective fibroblast...
View ArticleClik here to view.
CORRECTING and REPLACING Incyte Announces Positive Updated Results from Phase...
WILMINGTON, Del. Sixth paragraph, fourth sentence of release should read: Serous retinal detachment was observed in 4 percent of patients (Grade ≥3, 1 percent) with none of the cases resulting in...
View ArticleClik here to view.
エスポーが2019年度欧州イノベーション首都の1つに
フィンランド・エスポ （ビジネスワイヤ） — エスポー市は、2019年度の欧州イノベーション首都（iCapital）賞を受賞した6都市の1つになりました。9月25日にブリュッセルで開催された欧州リサーチ・アンド・イノベーション・デーズで、ナント（フランス）が新たな欧州イノベーション首都として発表されました。...
View ArticleClik here to view.
HISA and Vocera to Co-host Webinar Addressing Cognitive Overload Among...
SAN JOSE, Calif. Vocera Communications, Inc. (NYSE:VCRA), a recognised leader in clinical communication and workflow solutions, today announced that it is co-hosting a webinar with Health...
View ArticleClik here to view.
Fuzionaire Diagnostics Partners with Japan Medical Isotope Technology...
PASADENA, Calif. Fuzionaire Diagnostics (“Fuzionaire Dx”), in partnership with Tokyo-based radiopharmaceutical company Japan Medical Isotope Technology Development K.K. (“JAMIT”), today announced...
View ArticleClik here to view.
Clik here to view.
NantHealth®, GE Healthcare, AirStrip and iProcedures Join Forces to Present...
BANGKOK & CULVER CITY, Calif. NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will be presenting with GE Healthcare,...
View ArticleClik here to view.
Clik here to view.
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4...
NORTH BRUNSWICK, N.J. Adlai Nortye Ltd. (“Adlai Nortye” or “the Company”), a global clinical-stage biopharmaceutical company dedicated to discovery, development and commercialization of new and...
View ArticleClik here to view.
PHC株式会社と株式会社カケハシによる、「メディコム」ブランドのヘルスケアＩＴソリューションの販売にかかる契約締結、および「Pharnes」と「Musub...
東京 （ビジネスワイヤ） — PHC株式会社（本社：東京都港区、代表取締役社長：宮崎 正次、以下「PHC」）は、本日、株式会社カケハシ（本社：東京都中央区、代表取締役CEO:中尾 豊、以下「KAKEHASHI」）と、PHCが提供する「メディコム（＊）」ブランドのヘルスケアＩＴソリューションのKAKEHASHIによる販売に関して、セールスパートナーシップ契約を締結しましたのでお知らせいたします。...
View ArticleClik here to view.
DKT WomanCare Global Signs Distribution Agreement with IUD Manufacturer...
PARIS DKT WomanCare is proud to announce the signing of a distribution agreement with Pregna International Ltd. The agreement was signed in the new offices of DKT WomanCare in Paris in the presence...
View ArticleClik here to view.
TÜV Rheinland Commends the State of California Blue Light Resolution;...
COLOGNE, GERMANY & BEIJING Today in a follow-up to the passing of the California State Blue Light Resolution, TÜV Rheinland, the world leader in independent third-party testing and...
View ArticleClik here to view.
Clik here to view.
英国国家卫生与临床优化研究所维持先前对EXOGEN®超声波骨愈合系统的推荐
荷兰霍夫多普 (美国商业资讯)–骨愈合解决方案的全球领先者Bioventus已收到英国国家卫生与临床优化研究所(NICE)的通知，该中心已更新了其有关采用EXOGEN超声波骨愈合系统治疗长骨骨折不愈的指南(MTG12)。EXOGEN采用低强度脉冲超声波(LIPUS)帮助刺激机体的自然愈合过程、促进骨折愈合1。对于无法自愈的骨折，该产品的愈合率达86% 2，对于新发骨折的愈合则可加快38%...
View ArticleClik here to view.
Clik here to view.
Incyte Announces Positive 52-Week Results From a Randomized Phase 2 Study of...
WILMINGTON, Del. Incyte (Nasdaq:INCY) today announces positive 52-week results from its randomized, double-blind, dose-ranging, Phase 2 study evaluating ruxolitinib cream, a nonsteroidal,...
View ArticleClik here to view.
インサイト、白斑患者でルキソリチニブ・クリームを検討するランダム化第2相試験の良好な52週の結果を発表
米デラウェア州ウィルミントン （ビジネスワイヤ） — インサイト（Nasdaq:INCY）は本日、白斑の成人患者で非ステロイド系抗炎症JAK阻害薬療法としてのルキソリチニブ・クリームを評価するランダム化二重盲検用量範囲探索第2相試験について、良好な52週の結果を発表します。...
View Article